Yanfang Ma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yanfang Ma has a total of 102 co-authors. Here are the top co-authors by number of shared publications:
- Yaolong Chen
School of Public Health, Lanzhou University
11 shared publications - Zhaoxiang Bian
Vincent V.C Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China
10 shared publications - Xuan Yu
Chinese EQUATOR Centre, Hong Kong Baptist University, Hong Kong SAR, China
6 shared publications - Qi Wang
School of Nursing University of Hong Kong Hong Kong Hong Kong
5 shared publications - Hui Liu
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China
4 shared publications - Ke Xu
Vincent V.C. Woo Chinese Medicine Clinical Research Institute, School of Chinese Medicine, Hong Kong Baptist University, Hong Kong SAR, China
4 shared publications
Latest Publications
- Open Access
- 20 August 2026
- Published by Elsevier in EBioMedicine
- Vol. 131
The VAccine cLinical study reporting gUidEline: the VALUE checklist with explanation and elaboration
- 20 August 2026
- Published by Elsevier in EBioMedicine
- Vol. 131
Open AccessThe VAccine cLinical study reporting gUidEline: the VALUE checklist with explanation and elaboration
- Open Access
- 19 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101358
Clinical evidence on integrated Chinese-Western medicine for stroke rehabilitation
- 19 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101358
Open AccessClinical evidence on integrated Chinese-Western medicine for stroke rehabilitation
- Open Access
- 19 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101359
Clinical evidence on integrated Chinese-Western medicine for atopic dermatitis
- 19 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101359
Open AccessClinical evidence on integrated Chinese-Western medicine for atopic dermatitis
- Open Access
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101355
AI-empowered clinical evidence for integrated Chinese-Western medicine: Introduction to the ACE-iMed series and platform dissemination
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101355
Open AccessAI-empowered clinical evidence for integrated Chinese-Western medicine: Introduction to the ACE-iMed series and platform dissemination
- Open Access
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101356
Clinical evidence on integrated Chinese-Western medicine for primary dysmenorrhea
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101356
Open AccessClinical evidence on integrated Chinese-Western medicine for primary dysmenorrhea
- Open Access
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101354
Clinical evidence on integrated Chinese-Western medicine for rheumatoid arthritis
- 16 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101354
Open AccessClinical evidence on integrated Chinese-Western medicine for rheumatoid arthritis
- Open Access
- 10 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101351
Design and methodology of the AI-empowered Clinical Evidence for Integrated Chinese-Western Medicine (ACE-iMed) platform
- 10 May 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3) , 101351
Open AccessDesign and methodology of the AI-empowered Clinical Evidence for Integrated Chinese-Western Medicine (ACE-iMed) platform
- Open Access
- 8 April 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3)
The evidence bridge: Advancing integrated Chinese-Western medicine from clinical research to practice in Hong Kong
- 8 April 2026
- Published by Elsevier in Integrative Medicine Research
- Vol. 15 (3)
Open AccessThe evidence bridge: Advancing integrated Chinese-Western medicine from clinical research to practice in Hong Kong
- Open Access
- 26 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e72412
Using Large Language Models to Assess the Consistency of Randomized Controlled Trials on AI Interventions With CONSORT-AI: Cross-Sectional Survey
Background: Chatbots based on large language models (LLMs) have shown promise in evaluating the consistency of research. Previously, researchers used LLM to assess if randomized controlled trial (RCT) abstracts adhered to the CONSORT-Abstract guidelines. However, the consistency of artificial intelligence (AI) interventional RCTs aligning with the CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) standards by LLMs remains unclear. Objective: The aim of this study is to identify the consistency of RCTs on AI interventions with CONSORT-AI using chatbots based on LLMs. Methods: This cross-sectional study employed 6 LLM models to assess the consistency of RCTs on AI interventions. The sample selection is based on articles published in JAMA Network Open, which included a total of 41 RCTs. All queries were submitted to LLMs through an application programming interface with a temperature setting of 0 to ensure deterministic responses. One researcher posed the questions to each model, while another independently verified the responses for validity before recording the results. The Overall Consistency Score (OCS), recall, inter-rater reliability, and consistency of contents were analyzed. Results: We found gpt-4‐0125-preview has the best average OCS on the basis of the results obtained by JAMA Network Open authors and by us (86.5%, 95% CI 82.5%‐90.5% and 81.6%, 95% CI 77.6%‐85.6%, respectively), followed by gpt-4‐1106-preview (80.3%, 95% CI 76.3%‐84.3% and 78.0%, 95% CI 74.0%‐82.0%, respectively). The model with the worst average OCS is gpt-3.5-turbo-0125 on the basis of the results obtained by JAMA Network Open authors and by us (61.9%, 95% CI 57.9%‐65.9% and 63.0%, 95% CI 59.0%‐67.0%, respectively). Among the 11 unique items of CONSORT-AI, Item 2 (“State the inclusion and exclusion criteria at the level of the input data”) received the poorest overall evaluation across the 6 models, with an average OCS of 48.8%. For other items, those with an average OCS greater than 80% across the 6 models included Items 1, 5, 8, and 9. Conclusions: GPT-4 variants demonstrate strong performance in assessing the consistency of RCTs with CONSORT-AI. Nonetheless, refining the prompts could enhance the precision and consistency of the outcomes. While AI tools like GPT-4 variants are valuable, they are not yet fully autonomous in addressing complex and nuanced tasks such as adherence to CONSORT-AI standards. Therefore, integrating AI with higher levels of human supervision and expertise will be crucial to ensuring more reliable and efficient evaluations, ultimately advancing the quality of medical research.
- 26 September 2025
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 27 (1) , e72412
Open AccessUsing Large Language Models to Assess the Consistency of Randomized Controlled Trials on AI Interventions With CONSORT-AI: Cross-Sectional Survey
Background: Chatbots based on large language models (LLMs) have shown promise in evaluating the consistency of research. Previously, researchers used LLM to assess if randomized controlled trial (RCT) abstracts adhered to the CONSORT-Abstract guidelines. However, the consistency of artificial intelligence (AI) interventional RCTs aligning with the CONSORT-AI (Consolidated Standards of Reporting Trials-Artificial Intelligence) standards by LLMs remains unclear. Objective: The aim of this study is to identify the consistency of RCTs on AI interventions with CONSORT-AI using chatbots based on LLMs. Methods: This cross-sectional study employed 6 LLM models to assess the consistency of RCTs on AI interventions. The sample selection is based on articles published in JAMA Network Open, which included a total of 41 RCTs. All queries were submitted to LLMs through an application programming interface with a temperature setting of 0 to ensure deterministic responses. One researcher posed the questions to each model, while another independently verified the responses for validity before recording the results. The Overall Consistency Score (OCS), recall, inter-rater reliability, and consistency of contents were analyzed. Results: We found gpt-4‐0125-preview has the best average OCS on the basis of the results obtained by JAMA Network Open authors and by us (86.5%, 95% CI 82.5%‐90.5% and 81.6%, 95% CI 77.6%‐85.6%, respectively), followed by gpt-4‐1106-preview (80.3%, 95% CI 76.3%‐84.3% and 78.0%, 95% CI 74.0%‐82.0%, respectively). The model with the worst average OCS is gpt-3.5-turbo-0125 on the basis of the results obtained by JAMA Network Open authors and by us (61.9%, 95% CI 57.9%‐65.9% and 63.0%, 95% CI 59.0%‐67.0%, respectively). Among the 11 unique items of CONSORT-AI, Item 2 (“State the inclusion and exclusion criteria at the level of the input data”) received the poorest overall evaluation across the 6 models, with an average OCS of 48.8%. For other items, those with an average OCS greater than 80% across the 6 models included Items 1, 5, 8, and 9. Conclusions: GPT-4 variants demonstrate strong performance in assessing the consistency of RCTs with CONSORT-AI. Nonetheless, refining the prompts could enhance the precision and consistency of the outcomes. While AI tools like GPT-4 variants are valuable, they are not yet fully autonomous in addressing complex and nuanced tasks such as adherence to CONSORT-AI standards. Therefore, integrating AI with higher levels of human supervision and expertise will be crucial to ensuring more reliable and efficient evaluations, ultimately advancing the quality of medical research.
- Open Access
- 13 February 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 168, 111279
Reporting guidelines for traditional Chinese medicine could be improved: a cross-sectional study
- 13 February 2024
- Published by Elsevier in Journal of Clinical Epidemiology
- Vol. 168, 111279
Open AccessReporting guidelines for traditional Chinese medicine could be improved: a cross-sectional study